People: 3SBio Inc. (SSRX.O)

SSRX.O on Nasdaq

10.18USD
9 Feb 2010
Price Change (% chg)

$-0.07 (-0.68%)
Prev Close
$10.18
Open
--
Day's High
$10.35
Day's Low
$10.15
Volume
165,450
Avg. Vol
151,225
52-wk High
$14.45
52-wk Low
$4.18

view people for:

Summary

Name Age Since Current Position
Lou, Dan 74 Chairman of the Board
Lou, Jing 46 Chief Executive Officer, Director
Tan, Bo 36 2009 Chief Financial Officer
Chen, David 44 2008 Chief Operating Officer, Executive Vice President
Huang, Bin 48 Vice President - Human Resources, Director
Xu, Liping 55 Vice President, Director
Wei, Yingfei 48 2006 Chief Scientific Officer, Vice President - Business Development
Su, Dongmei 39 Chief Technology Officer
Tong, Norman 40 2009 Controller
Li, Ke 41 Corporate Secretary
Wizel, Lawrence 66 Independent Director
Qi, Moujia 76 Independent Director
Yu, Mingde 63 Independent Director
» Insider Trading

Biographies

Name Description
Lou, Dan Mr. Dan Lou is co-founder and Chairman of the Board of 3SBio Inc. Mr. Lou established Shenyang Sunshine in 1993 and served as president and chief engineer until 2003. From 1961 to 1993, Mr. Lou served several positions in Shenhou Institute of Military Medicine, including assistant military doctor, military doctor, deputy director and director of Department of Microbiology and Immunology. Currently Mr. Lou also serves as an executive director at China Medicinal Biotech Association. Mr. Lou graduated from the Third Military Medical University in 1955.
Lou, Jing Dr. Jing Lou is co-founder, chief executive officer and director of 3SBio Inc. He has served as the chief executive officer of Shenyang Sunshine since 2000. He joined Shenyang Sunshine as director of research and development in 1995. Prior to joining the Company, Dr. Lou founded Lifegen, Inc., a Maryland corporation and an investee company of Shenyang Sunshine, to optimize the manufacturing processes for EPIAO and TPIAO in the United States. Dr. Lou completed his post-doctoral study at the United States National Institute of Health in 1995. He received his Ph.D. in Molecular and Cell Biology in 1993 from Fordham University, where he researched interferon signal transduction of gene regulation, and received his medical doctor degree in 1985 from Shanghai Second Military Medical University.
Tan, Bo Mr. Tan has been appointed as Chief Financial Officer of 3SBio Inc., effective February 1, 2009. Since joining 3SBio in October 2008, Mr. Tan has been acting as the financial advisor for the company, providing advice on the company's capital market initiatives and overseeing the company's treasury functions. He has extensive experience within the financial and pharmaceutical industries, having worked across private equity, equity research and commercial practice. Previously, he has served as the Executive Director and a member of Investment Committee for Bohai Industrial Fund Management Company, a private equity fund in China. Earlier in his career, he spent six years in the pharmaceutical industry with Eli Lilly & Company and EMD Pharmaceuticals, Inc in North America and went on to serve as a China healthcare and consumer analyst at Lehman Brothers Asia and Macquarie Securities in Hong Kong. Mr. Tan received his MBA degree from Thunderbird School of International Management, an MA degree in economics from the University of Connecticut and a BA degree in economics from Renmin University of China. Mr. Tan is also a CFA (Chartered Financial Analyst).
Chen, David Dr. David Chen is Chief Operating Officer, Executive Vice President of 3SBio Inc. Dr. Chen held various managerial positions in the United States pharmaceutical industry, including business development, sales and marketing, market research, new product development and research and development portfolio management both with Eli Lilly and GlaxoSmithKline from 1998 to 2006. Prior to his experience in the United States, Dr. Chen was a practicing orthopedic surgeon at Shanghai Medical University from 1989 to 1992. He received a medical degree from the First Military Medical University in Guangzhou, China and received a master’s degree in Business Administration from the Darden School of Business at the University of Virginia.
Huang, Bin Mr. Bin Huang is Vice President - Human Resources, Director of 3SBio Inc. Mr. Huang has served as vice president in charge of human resources and legal matters since joining Shenyang Sunshine in 1993. Before that, he acted as office manager for the Shenyang Army Medical Research Center from 1976 to 1993. He received his master’s degree in Business Administration from Qinghua University in 2002 and a bachelor’s degree in engineering from Northeast University in 1987.
Xu, Liping Ms. Liping Xu is Vice President, Director of 3SBio Inc. Ms. Xu has served as the executive director of Shenyang Sunshine from 1993 to 2002. Prior to joining Shenyang Sunshine, she worked at the Shenhou Institute of Military Medicine. Ms. Xu is a senior engineer. She graduated from Shenyang Pharmaceutical University with a master’s degree in microbiology and pharmacology in 1996.
Wei, Yingfei Dr. Yingfei Wei is Chief Scientific Officer, Vice President - Business Development , joined 3SBio Inc., in August 2006. She has over fifteen years of research and development experience in the biotechnology and pharmaceutical sectors. Before joining the Company, she was the co-founder, president and chief executive officer of Elixirin Corporation from 2004 to 2005, responsible for overseeing contract research, manufacturing, regulatory approvals and marketing of anti-aging products in the United States and China. Before that, she was director of biotechnology research at Bayer HealthCare Global from 1998 to 2004 and group leader at the discovery research department of Human Genome Sciences Inc. from 1993 to 1998. Dr. Wei is named inventor for 37 patents and has authored several publications, primarily in the areas of protein and antibody drug discovery and genomics. Dr. Wei was a postdoctoral fellow at Harvard University’s School of Public Health in 1993. She received her Ph.D. in biochemistry from the University of California in 1990 and a bachelor’s degree in biochemistry from Beijing University in 1983.
Su, Dongmei Ms. Dongmei Su is chief technology officer of 3SBio Inc., responsible for research and development and manufacturing process engineering. She is the named co-inventor for four of patents. Ms. Su joined Shenyang Sunshine in 1993. She served as director of research and development and manufacturing since 1997. She received her bachelor’s degree in biochemical engineering from Jilin University in 1992 and her master’s degree in microbiology and pharmacology from Shenyang Pharmaceutical University in 2001.
Tong, Norman Mr. Norman Tong is Controller of 3SBio Inc., in March 2009. Mr. Tong have previously worked with various Fortune 500 companies, including Pepsi and others, as a senior finance team leader. Mr. Tong received a bachelor’s degree in accounting from National University of Finance and Economics in 1992 and a master’s degree in finance from Liaoning University.
Li, Ke Mr. Ke Li is corporate secretary of 3SBio Inc. He is responsible for all corporate and government regulatory matters. Mr. Li has served as the corporate secretary of Shenyang Sunshine since 1996. He joined the Company in 1993 and held various administrative positions at Shenyang Sunshine before he was appointed corporate secretary. Mr. Li received his master’s degree in Business Administration from Liaoning University in 2001 and his bachelor’s degree in engineering from Jilin University in 1988.
Wizel, Lawrence Mr. Lawrence S. Wizel has served as a Independent Director of 3SBio Inc., since September 2006. He was a partner at Deloitte & Touche LLP from 1980 to June 2006. He also served as deputy professional practice director and northeast region China service group leader of Deloitte & Touche LLP from 2002 to 2006. He has extensive experience serving a diverse client base of both publicly-held and private companies and has also assisted numerous Chinese companies with their filings with the Securities and Exchange Commission. He is a member of the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants. He also serves as the Chairman of Board of Trustees of Helen Keller Services for the Blind. He received his bachelor’s degree in science from Michigan State University.
Qi, Moujia Mr. Moujia Qi is Independent Director of 3SBio Inc., since August 2006. He has also served as the Chairman of the China Starch Industry Association for the past five years. He was the deputy director and chief engineer of Huabei Pharmaceutical Factory and has held several management positions in various state-owned companies in the pharmaceutical industry. He has also served as the deputy director and chief director of the State Medicine Administration of the PRC before he retired in 1994.
Yu, Mingde Mr. Mingde Yu is Independent Director of 3SBio Inc., since February 2008. He has extensive experience in manufacturing and distribution management in the pharmaceutical industry in China. He has held a number of senior positions both in the government and the private sectors, including as the Chief Technology Officer and the Head of Manufacturing at both Liaoning Fuxi Pharmaceutical Co. and Fuxi Traditional Chinese Medicine Co. (from 1978 to 1983), Bureau Chief of the Fuxi City Food & Drug Administration from 1983 to 1991, Bureau Chief of the Liaoning Provincial Food & Drug Administration from 1991 to 1997, Drug Department Chief of the Economic Operations Bureau of the State Economic and Trade Committee from 1997 to 1998 and Vice-Bureau Chief of Economic Operations Department of the National Development Reform Committee from 1998 to 2003. Mr. Yu is currently the honorary Chairman and Director of the Beijing Pharmaceutical Group and is the Vice Committee Chair for the China Pharmaceutical Enterprises Administrative Association and China Medical Entrepreneur Association. Mr. Yu also holds senior consultancy roles with the China Chemical Drug Association and the National Pharmaceutical Industry & Commerce Association. Mr. Yu graduated from the Macromolecule Materials and Engineering Department, Chemical Technology School at Dalian University of Technology.

Basic Compensation

Name Fiscal Year Total
Lou, Dan --
Lou, Jing --
Tan, Bo --
Chen, David --
Huang, Bin --
Xu, Liping --
Wei, Yingfei --
Su, Dongmei --
Tong, Norman --
Li, Ke --
Wizel, Lawrence --
Qi, Moujia --
Yu, Mingde --
As Of 

Options Compensation

Name Options Value
Lou, Dan 0 0
Lou, Jing 0 0
Tan, Bo 0 0
Chen, David 0 0
Huang, Bin 0 0
Xu, Liping 0 0
Wei, Yingfei 0 0
Su, Dongmei 0 0
Tong, Norman 0 0
Li, Ke 0 0
Wizel, Lawrence 0 0
Qi, Moujia 0 0
Yu, Mingde 0 0

Insider Trading

» Full list on Insider Trading
view people for: